Application of Nanomaterials in Drug Delivery and Drug Release

Dear Colleagues,

The application of nanomaterials in drug delivery and drug release has garnered significant attention due to their potential to revolutionize pharmaceutical treatments. Nanomaterials, such as nanoparticles, liposomes, and dendrimers, offer unique properties such as enhanced bioavailability, controlled release, and targeted delivery, which are critical for improving the efficacy and reducing the side-effects of drugs. Current research focuses on optimizing the design and functionalization of nanomaterials to enhance their stability, biocompatibility, and specificity to target tissues or cells.

Recent studies have highlighted the challenges in scaling up nanomaterial-based drug delivery systems, including issues related to toxicity, immune response, and the complexity of production methods. Advances in nanomaterial engineering, including the incorporation of stimuli-responsive mechanisms, are pushing the boundaries of controlled and sustained drug release.

This topic invites contributions that explore novel nanomaterial-based strategies for drug delivery, innovations in targeted therapies, and the challenges in translating these technologies from laboratory settings to clinical applications. We welcome research articles and reviews addressing both theoretical advancements and practical applications in this dynamic field.

Dr. Diana Iulia Savu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.